Results 111 to 120 of about 43,621 (186)

An inverse probability of treatment weighted comparison between vedolizumab, ustekinumab, and tofacitinib in anti-TNF-experienced ulcerative colitis patients. [PDF]

Ther Adv Gastroenterol
Tursi A, Pasta A, Elisei W, Barberio B, Bertin L, Mocci G, Maconi G, Gravina AG, Pellegrino R, Bodini G, Papa A, Savarino EV, Italian Network for Inflammatory Bowel Diseases (IN-IBD).   +12 more
europepmc   +1 more source

Successful Treatment of Anti-Jo-1 Positive Inflammatory Myopathy With Tofacitinib. [PDF]

Case Rep Rheumatol
Timsans J, Hokkanen AM, Rautavaara J, Kerola A, Huovinen S, Kauppi M.   +5 more
europepmc   +1 more source

JAK/STAT inhibition reprograms T cell activation and metabolism in inflammatory arthritis patients. [PDF]

Inflamm Res
Marzaioli V, Brugman AAI, O'Dowd N, Floudas A, Gorman A, Orr C, Veale DJ, Fearon U.   +7 more
europepmc   +1 more source

GENERATIVE AI TOWARDS A COMPARATIVE ANALYSIS OF HOSPITALIZATION RATES AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH INFLIXIMAB, VEDOLIZUMAB, AND TOFACITINIB IN THE PUBLIC HEALTHCARE SYSTEM IN BRAZIL: A NATIONWIDE STUDY. [PDF]

Arq Gastroenterol
Valverde DA, Quaresma AB, Villamil MPG, Moraes TP, Kotze PG.   +4 more
europepmc   +1 more source

Real-World Effectiveness of Biologic and Targeted Synthetic Therapies in Rheumatoid Arthritis: a Multicenter Study from Rheumatoid Arthritis Saudi Database (RASD). [PDF]

Open Access Rheumatol
Almoallim HM, Bahlas SM, Bawazir Y, Hussein AH, Attia GM, Manasfi H, Bafadhl ZA, Asiri AM, Ali AR, Alomair MM, Alsharaif MM, Almalki HH, Siddiqui MI, Alhazmi AS, Attar SM.   +14 more
europepmc   +1 more source

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study. [PDF]

JGH Open
Gilmore R, Pham T, Fernandes RG, Lo S, Wright EK, Rosella O, De Cruz P, Andrew B, Vasudevan A, Gazelakis K, Moore GT, Thin L, Au K, Ghaly S, Chen C, Mohsen W, Goodwin T, Sparrow MP, Ward MG, Chew M, Garg M, Shelton E, Lawrance IC, Thorat A, da Fonseca Pereira C, Begun J, An YK.   +26 more
europepmc   +1 more source

Efficacy and safety of dual-targeted therapy with tofacitinib and TNF inhibitors in refractory spondyloarthritis: a case series from a tertiary care center. [PDF]

Ther Adv Musculoskelet Dis
Agrawal A, Yadav SS, Balakrishnan C.
europepmc   +1 more source

Real-World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi-Center Cohort Study. [PDF]

Clin Transl Sci
Jin Y, Cao J, Yang S, Liu Y, Tang R, Zeng Y, Huang C, Luo Y.   +7 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study. [PDF]

Adv Ther
Tursi A, Pasta A, Elisei W, Barberio B, Mocci G, Savarino EV, de Barba C, Maconi G, Cataletti G, Scaldaferri F, Napolitano D, Costa F, Ceccarelli L, Marzo M, Monterubbianesi R, di Fonzo M, Lombardi G, Patturelli M, Ribaldone DG, Bertani L, Rodino' S, Sebkova L, Bodini G, Pranzo G, Serio M, Scarcelli A, Luppino I, Ferronato A, Spagnuolo R, Luzza F, Morano D, Gravina AG, Pellegrino R, Vespere G, Sedda S, Allegretta L, Fanigliulo L, Grossi L, Cortellini F, Forti G, Neve V, Piergallini S, Scarozza P, Bevevino G, Iacopini F, Capone P, Gaiani F, Kayali S, Mucherino C, D'antonio E, D'ascoli B, Colucci R, Bachetti F, Giorgetti GM, Clemente V, Pagnini C, Cuomo A, Donnarumma L, Onidi FM, Satta PU, Picchio M, Papa A, Italian Network for Inflammatory Bowel Diseases (IN-IBD).   +62 more
europepmc   +1 more source

Efficacy of tofacitinib in the treatment of refractory palmoplantar psoriasis (non-pustular): case report and literature review. [PDF]

An Bras Dermatol
Sakiyama PH, Miot LDB, Miot HA.
europepmc   +1 more source